Literature DB >> 6522733

Goodness of fit methods for the proportional hazards regression model: a review.

R Kay.   

Abstract

The proportional hazards regression model is now used extensively in survival time studies. Although the model (hazard function, lambda (t;x) = lambda 0 (t)e beta' x) can be considered to be partially distribution-free, the following assumptions regarding the distribution of survival time are made: 1. Hazard functions for any two individuals are proportional. Thus (Formula: see text) is independent of t. 2. Independent variables affect the log hazard in an additive way (Formula: see text) This paper reviews methods available for assessing these assumptions in particular cases.

Mesh：

Year:  1984        PMID： 6522733

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN： 0398-7620            Impact factor:   1.019


  7 in total

1.  MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma.

Authors:  Wei Pei; Chen Wang; Hai Liao; Xiaobo Chen; Yunyun Wei; Xia Huang; Xueli Liang; Huayan Bao; Danke Su; Guanqiao Jin
Journal:  BMC Cancer       Date:  2022-07-06       Impact factor: 4.638

2.  Is Chikungunya Virus Infection an Independent Risk Factor for 2-Year Mortality in Older Afro-Caribbean Subjects?

Authors:  Lidvine Godaert; Camille Nicolon; Fatiha Najioullah; Lukshe Kanagaratnam; Raymond Césaire; Moustapha Dramé
Journal:  Infect Drug Resist       Date:  2020-07-10       Impact factor: 4.003

3.  Influence of dietary factors on colorectal cancer survival.

Authors:  X Dray; M-C Boutron-Ruault; S Bertrais; D Sapinho; A-M Benhamiche-Bouvier; J Faivre
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

4.  Prognostic factors of inhospital death in elderly patients: a time-to-event analysis of a cohort study in Martinique (French West Indies).

Authors:  Lidvine Godaert; Seendy Bartholet; Fréderique Dorléans; Fatiha Najioullah; Sebastien Colas; Jean-Luc Fanon; André Cabié; Raymond Césaire; Moustapha Dramé
Journal:  BMJ Open       Date:  2018-01-23       Impact factor: 2.692

5.  PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase.

Authors:  Juan M Alonso-Dominguez; Luis Felipe Casado; Eduardo Anguita; Maria Teresa Gomez-Casares; Ismael Buño; Francisca Ferrer-Marín; Alicia Arenas; Rafael Del Orbe; Rosa Ayala; Pilar Llamas; Rocio N Salgado; Santiago Osorio; Pedro Sanchez-Godoy; Carmen Burgaleta; Ignacio Mahíllo-Fernández; Valentin Garcia-Gutierrez; Juan Luis Steegmann; Joaquín Martinez-Lopez
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

6.  Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis.

Authors:  Florence C Riché; Xavier Dray; Marie-Josèphe Laisné; Joaquim Matéo; Laurent Raskine; Marie-José Sanson-Le Pors; Didier Payen; Patrice Valleur; Bernard P Cholley
Journal:  Crit Care       Date:  2009-06-24       Impact factor: 9.097

7.  A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes.

Authors:  An Tran-Duy; Josh Knight; Andrew J Palmer; Dennis Petrie; Tom W C Lung; William H Herman; Björn Eliasson; Ann-Marie Svensson; Philip M Clarke
Journal:  Diabetes Care       Date:  2020-06-12       Impact factor: 19.112
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.